FDA advisors to review Johnson & Johnson vaccine

COLUMBIA, SC (WOLO)– The United States could have authorization to begin administering a third COVID-19 vaccine in a few days. Food and Drug Administration advisors are meeting Friday to review the Johnson & Johnson vaccine.

If they recommend it to the FDA, that agency could sign off on it Friday or Saturday. Research shows the single-dose Johnson & Johnson vaccine is about 66% effective.

Categories: National News